Novocure Ltd Ord Sh (NVCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NVCR | AZN | AMGN | GILD | VRTX |
| Company | Novocure Ltd Ord Sh | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 13.07 | 89.68 | 329.95 | 123.73 | 440.54 |
| High | 13.64 | 90.79 | 343.98 | 129.39 | 465.14 |
| Low | 13.06 | 89.04 | 329.32 | 122.68 | 439.91 |
| Latest | 13.56 | 90.54 | 343.60 | 129.11 | 461.14 |
| Change | +0.55 | +0.60 | +12.60 | +4.97 | +19.06 |
| % Change | +4.19% | +0.67% | +3.81% | +4.00% | +4.31% |
| Volume | 945,600 | 9,023,641 | 4,031,785 | 7,277,047 | 2,288,662 |
| 20-Day Average Volume | 1,099,145 | 8,110,627 | 2,291,404 | 5,717,772 | 1,256,108 |
| Previous Close | 13.02 | 89.94 | 331.00 | 124.14 | 442.08 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 13.67 | 93.05 | 330.28 | 123.29 | 457.38 |
| 20-Day Raw Stochastic | 32.34% | 20.08% | 98.53% | 97.76% | 54.92% |
| 20-Day Relative Strength | 52.26 | 47.69 | 60.47 | 58.94 | 54.99 |
| Weighted Alpha | -36.78 | +32.30 | +27.47 | +36.64 | +7.61 |
| Today's Opinion | 8% Sell | 64% Buy | 88% Buy | 96% Buy | 72% Buy |
| Previous Opinion | 24% Sell | 64% Buy | 80% Buy | 72% Buy | 40% Buy |
| Last Month's Opinion | 40% Sell | 88% Buy | 72% Buy | 56% Buy | 72% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.66% since 01/13/26 | -4.20% since 01/13/26 | +5.95% since 01/13/26 | +6.04% since 01/13/26 | +1.42% since 01/13/26 |
| Low | 12.80 on 01/20/26 | 89.04 on 01/21/26 | 321.71 on 01/20/26 | 120.94 on 01/15/26 | 429.00 on 01/20/26 |
| High | 14.07 on 01/16/26 | 96.43 on 01/14/26 | 343.98 on 01/21/26 | 129.39 on 01/21/26 | 465.14 on 01/21/26 |
| 1-Month | |||||
| %Chg | +5.61% since 12/19/25 | -0.90% since 12/19/25 | +4.95% since 12/19/25 | +3.88% since 12/19/25 | +1.08% since 12/19/25 |
| Low | 12.80 on 12/22/25 | 89.04 on 01/21/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 429.00 on 01/20/26 |
| High | 15.15 on 01/09/26 | 96.51 on 01/07/26 | 343.98 on 01/21/26 | 129.39 on 01/21/26 | 487.52 on 01/07/26 |
| 3-Month | |||||
| %Chg | -4.03% since 10/21/25 | +8.80% since 10/21/25 | +14.10% since 10/21/25 | +4.05% since 10/21/25 | +8.18% since 10/21/25 |
| Low | 10.70 on 11/07/25 | 80.48 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 403.16 on 11/04/25 |
| High | 15.15 on 01/09/26 | 96.51 on 01/07/26 | 346.38 on 12/03/25 | 129.39 on 01/21/26 | 487.52 on 01/07/26 |
| 6-Month | |||||
| %Chg | -15.78% since 07/21/25 | +31.75% since 07/21/25 | +16.13% since 07/21/25 | +19.24% since 07/21/25 | +0.58% since 07/21/25 |
| Low | 10.70 on 11/07/25 | 69.42 on 07/22/25 | 269.77 on 09/26/25 | 108.06 on 07/22/25 | 362.50 on 08/11/25 |
| High | 16.70 on 07/23/25 | 96.51 on 01/07/26 | 346.38 on 12/03/25 | 129.39 on 01/21/26 | 487.52 on 01/07/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,457,446 | 278,977,344 | 178,237,216 | 154,018,016 | 112,164,088 |
| Shares Outstanding, K | 111,982 | 3,101,816 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 605,220,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -168,630,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 167,200,000 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -37,270,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 0.73 | 0.34 | 0.45 | 0.33 | 0.31 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.33 on 10/30/25 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 02/26/26 | 02/10/26 | 02/03/26 | 02/10/26 | 02/09/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.65 | 15.11 | 15.25 | 28.83 |